Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 2004, p. 1779-1781, Vol. 42, No. 4
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.4.1779-1781.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
ska-Sawicka,2 J. Kur,2 E. Petersen,3,4 H. V. Nielsen,3 M. Stankiewicz,5 I. Andrzejewska,6 and P. Myjak1*
Department of Tropical Parasitology, Interfaculty Institute of Maritime and Tropical Medicine, Medical University of Gda
sk, 81-519 Gdynia,1
Department of Microbiology, Gda
sk University of Technology, 80-952 Gda
sk,2
Department of Biology and Medical Parasitology, Medical University of Pozna
, 87-100 Pozna
, Poland,4
Laboratory of Parasitology, Statens Seruminstitut, DK-2300 Copenhagen, Denmark,3
Animal and Food Sciences Division, Lincoln University, Canterbury, New Zealand,5
Department of Laboratory Medicine, Karolinska Institute, S14186 Stockholm, Sweden6
Received 16 July 2003/ Returned for modification 10 November 2003/ Accepted 9 January 2004
Toxoplasma gondii SAG1, GRA1, and GRA7 recombinant antigens may be regarded as tools for the detection of T. gondii immunoglobulin G antibodies in persons with chronic and acute toxoplasmosis. GRA7 is more correlated with acute toxoplasmosis. A combination of these antigens will increase the sensitivity of enzyme-linked immunosorbent assays.
sk, 81-519 Gdynia, ul. Powstania Styczniowego 9 b, Poland. Phone: 48-58-6998547. Fax: 48-58-6223354. E-mail: pemyjak{at}immt.gdynia.pl.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|